Filing Details

Accession Number:
0001209191-17-047862
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-07 16:02:33
Reporting Period:
2017-08-04
Filing Date:
2017-08-07
Accepted Time:
2017-08-07 16:02:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1566373 Spring Bank Pharmaceuticals Inc. SBPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296999 David Arkowitz C/O Spring Bank Pharmaceuticals, Inc.
86 South Street
Hopkinton MA 01748
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-04 200 $12.25 17,086 No 4 P Direct
Common Stock Acquisiton 2017-08-04 2,300 $12.24 19,386 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct